Rebecca Critchley-Thorne
Fondatore presso Cernostics, Inc.
Profilo
Rebecca Critchley-Thorne is the founder and holds the title of Vice President-Research & Development at Cernostics, Inc. which is founded in 2008.
She also worked as a Senior Scientist at Acelerate, Inc. Dr. Critchley-Thorne earned a doctorate degree from Imperial College London.
Posizioni attive di Rebecca Critchley-Thorne
| Società | Posizione | Inizio |
|---|---|---|
Cernostics, Inc.
 Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Fondatore | 01/01/2008 |
Precedenti posizioni note di Rebecca Critchley-Thorne
| Società | Posizione | Fine |
|---|---|---|
Acelerate, Inc.
 Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Rebecca Critchley-Thorne
| Imperial College London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Cernostics, Inc.
Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Health Technology |
Acelerate, Inc.
Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
- Borsa valori
- Insiders
- Rebecca Critchley-Thorne
